• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/22 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 207/22

Total number of patents in this class: 118

10-year publication summary

11
6
7
5
8
6
9
10
6
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
ObsEva S.A.
58
9
FMC Corporation
834
8
Allergan, Inc.
2313
6
Bayer Cropscience AG
1983
6
KYORIN Pharmaceutical Co., Ltd.
169
6
Abbvie Inc.
1817
4
Takeda Pharmaceutical Company Limited
2721
4
ReproNovo SA
4
3
Novartis AG
10612
2
Centre National de La Recherche Scientifique
10706
2
Aix-Marseille Universite'
39
2
Inserm (institut National de La Sante et de La Recherche Medicale)
3374
2
Institut Jean Paoli & Irene Calmettes
138
2
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
70
2
Calico Life Sciences LLC
104
2
Inspirna, Inc.
38
2
Bio Genuine (Shanghai) Biotech Co., Ltd
2
2
Bristol-myers Squibb Company
4826
1
3m Innovative Properties Company
17719
1
BASF SE
21098
1
Other owners 51